Open Beta
TREN
MetriLume
TREN

US marketsLGNXZ

SEC-sourced researchBeta

LGNXZ

LIGAND PHARMACEUTICALS INC

Company comparison ↗

Data passport

CIK
0000886163
Exchange
OTC
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Sep 24, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 131,314,000.0000 USD; December 2024: 167,133,000.0000 USD; December 2025: 268,087,000.0000 USD268.1M USD0 USD0December 2023December 2024December 2025
LGNXZ · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023131,314,000.0000Feb 27, 2026
December 2024167,133,000.0000Feb 27, 2026
December 2025268,087,000.0000Feb 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025268,087,000.0000124,453,000.000049,359,000.00001,560,637,000.0000543,425,000.0000Feb 27, 2026
December 2024167,133,000.0000-4,032,000.000097,047,000.0000941,774,000.0000111,335,000.0000Feb 27, 2026
December 2023131,314,000.000052,154,000.000049,577,000.0000——Feb 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$268.09MDecember 2025Feb 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$167.13MDecember 2024Feb 27, 202610-K
Net incomeNetIncomeLoss$124.45MDecember 2025Feb 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$49.36MDecember 2025Feb 27, 202610-K
Total assetsAssets$1.56BDecember 2025Feb 27, 202610-K
Total liabilitiesLiabilities$543.43MDecember 2025Feb 27, 202610-K

New filings

Explore methodology ↗